Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K P Madden

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Stroke|July 1, 1991
Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatmentW M Clark, K P Madden, R Rothlein, et al.
Stroke|March 1, 1992
Tissue plasminogen activator cerebrovascular thrombolysis in rabbits is dependent on the rate and route of administrationD Russell, K P Madden, W M Clark, et al.
Journal of Neurosurgery|October 1, 1991
Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion moleculeW M Clark, K P Madden, R Rothlein, et al.
Neurology|November 1, 1995
Accuracy of initial stroke subtype diagnosis in the TOAST study. Trial of ORG 10172 in Acute Stroke TreatmentK P Madden, P N Karanjia, H P Adams, et al.
Stroke|July 1, 1991
Cerebral hemorrhagic risk of aspirin or heparin therapy with thrombolytic treatment in rabbitsW M Clark, K P Madden, P D Lyden, et al.
Respiration Physiology|May 1, 1986
Postsynaptic potentials of bulbar respiratory neurons of the turtleR Takeda, J E Remmers, J P Baker, et al.
Stroke|February 1, 1991
Detection of arterial emboli using Doppler ultrasound in rabbitsD Russell, K P Madden, W M Clark, et al.
Stroke|November 1, 1990
Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected]P D Lyden, K P Madden, W M Clark, et al.
JAMA|December 11, 1999
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic StrokeW M Clark, S Wissman, G W Albers, et al.
Brain Research|December 24, 1990
Treatment with conotoxin, an 'N-type' calcium channel blocker, in neuronal hypoxic-ischemic injuryK P Madden, W M Clark, F W Marcoux, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Stroke|July 1, 1991
Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatmentW M Clark, K P Madden, R Rothlein, et al.
Stroke|March 1, 1992
Tissue plasminogen activator cerebrovascular thrombolysis in rabbits is dependent on the rate and route of administrationD Russell, K P Madden, W M Clark, et al.
Journal of Neurosurgery|October 1, 1991
Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion moleculeW M Clark, K P Madden, R Rothlein, et al.
Neurology|November 1, 1995
Accuracy of initial stroke subtype diagnosis in the TOAST study. Trial of ORG 10172 in Acute Stroke TreatmentK P Madden, P N Karanjia, H P Adams, et al.
Stroke|July 1, 1991
Cerebral hemorrhagic risk of aspirin or heparin therapy with thrombolytic treatment in rabbitsW M Clark, K P Madden, P D Lyden, et al.
Respiration Physiology|May 1, 1986
Postsynaptic potentials of bulbar respiratory neurons of the turtleR Takeda, J E Remmers, J P Baker, et al.
Stroke|February 1, 1991
Detection of arterial emboli using Doppler ultrasound in rabbitsD Russell, K P Madden, W M Clark, et al.
Stroke|November 1, 1990
Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected]P D Lyden, K P Madden, W M Clark, et al.
JAMA|December 11, 1999
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic StrokeW M Clark, S Wissman, G W Albers, et al.
Brain Research|December 24, 1990
Treatment with conotoxin, an 'N-type' calcium channel blocker, in neuronal hypoxic-ischemic injuryK P Madden, W M Clark, F W Marcoux, et al.
Pageof 2